QGEN PE Ratio & Valuation, Is QGEN Overvalued

Historical Valuation

Qiagen NV (QGEN) is now in the Undervalued zone, suggesting that its current forward PE ratio of 18.37 is considered Undervalued compared with the five-year average of 21.43. The fair price of Qiagen NV (QGEN) is between 44.04 to 52.96 according to relative valuation method. Compared to the current price of 41.21 USD , Qiagen NV By Undervalued By 6.43%.

Relative Value

Fair Zone

44.04-52.96

Current Price：41.21

6.43%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Qiagen NV (QGEN) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Qiagen NV (QGEN) has a current Price-to-Book (P/B) ratio of 2.69. Compared to its 3-year average P/B ratio of 2.74, the current P/B ratio is approximately -1.91% higher. Relative to its 5-year average P/B ratio of 3.11, the current P/B ratio is about -13.63% higher. Qiagen NV (QGEN) has a Forward Free Cash Flow (FCF) yield of approximately 4.89%. Compared to its 3-year average FCF yield of 4.47%, the current FCF yield is approximately 9.38% lower. Relative to its 5-year average FCF yield of 4.71%, the current FCF yield is about 3.69% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for QGEN competitors is 3.15, providing a benchmark for relative valuation. Qiagen NV Corp (QGEN.N) exhibits a P/S ratio of 4.54, which is 44.3% above the industry average. Given its robust revenue growth of 3.69%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of QGEN increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of QGEN in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is QGEN currently overvalued or undervalued?

What is Qiagen NV (QGEN) fair value?

QGEN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Qiagen NV (QGEN) is between 44.04 to 52.96 according to relative valuation method.

How does QGEN's valuation metrics compare to the industry average?

The average P/S ratio for QGEN's competitors is 3.15, providing a benchmark for relative valuation. Qiagen NV Corp (QGEN) exhibits a P/S ratio of 4.54, which is 44.30% above the industry average. Given its robust revenue growth of 3.69%, this premium appears unsustainable.

What is the current P/B ratio for Qiagen NV (QGEN) as of Mar 12 2026?

As of Mar 12 2026, Qiagen NV (QGEN) has a P/B ratio of 2.69. This indicates that the market values QGEN at 2.69 times its book value.

What is the current FCF Yield for Qiagen NV (QGEN) as of Mar 12 2026?

As of Mar 12 2026, Qiagen NV (QGEN) has a FCF Yield of 4.89%. This means that for every dollar of Qiagen NV's market capitalization, the company generates 4.89 cents in free cash flow.

What is the current Forward P/E ratio for Qiagen NV (QGEN) as of Mar 12 2026?

As of Mar 12 2026, Qiagen NV (QGEN) has a Forward P/E ratio of 18.37. This means the market is willing to pay $18.37 for every dollar of Qiagen NV's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Qiagen NV (QGEN) as of Mar 12 2026?

As of Mar 12 2026, Qiagen NV (QGEN) has a Forward P/S ratio of 4.54. This means the market is valuing QGEN at $4.54 for every dollar of expected revenue over the next 12 months.

QGEN Valuation